1 / 12

Cardiomyopathy Market

Cardiomyopathy market, size, share, market intelligence, company profiles, market trends, strategy, research report, analysis, forecast 2018-2023

omrglobal
Download Presentation

Cardiomyopathy Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global cardiomyopathy market research and forecast 2018-2023 Medical Devices Pharmaceuticals

  2. DEFINITION The cause of the cardiomyopathy is unknown. Contributing factors for acquired cardiomyopathy include long-term high blood pressure, heart tissue damage from a heart attack, chronic rapid heart rate, heart valve problems, metabolic disorders, such as obesity, thyroid disease or diabetes and nutritional deficiencies of essential vitamins or minerals, such as thiamin (vitamin B-1). According to the OMR analysis, the global cardiomyopathy market is growing significantly during the forecast period (2018-2023).

  3. MARKET MOTIVATORS • Advancement in understanding and managing cardiomyopathy • Rise in incidences of congestive heart failure, coronary heart disease, and heart attack • Increasing trend of minimally invasive technology • Availability of remote monitoring solutions

  4. MARKET RESTRAINT • High cost of diagnosis and treatment • Lack of public awareness

  5. MARKET OPPORTUNITY • Increasing medical tourism in emerging countries • R&d exploration is on rise

  6. REGIONAL ANALYSIS

  7. MARKET SEGMENTATION By type • Dilated cardiomyopathy • Hypertrophic cardiomyopathy • Restrictive cardiomyopathy • Arrhythmogenic right ventricular dysplasia • Unclassified cardiomyopathy

  8. MARKET SEGMENTATION By diagnosis test • Chest x-ray • Echocardiogram • Electrocardiogram (ecg) • Treadmill stress test • Cardiac catheterization • Cardiac mri • Cardiac ct scan • Blood tests • Genetic testing or screening

  9. MARKET SEGMENTATION By treatment • Medication • Surgically implanted devices • Nonsurgical procedures • Surgery

  10. MARKET SEGMENTATION By end user • Homecare • Hospitals and clinics • Diagnostic center • Other

  11. COMPANY PROFILES • Abbott diagnostics • Array biopharma, inc. • Astrazeneca plc • Becton and dickson & co. • Bg medicine inc. To be continued…

  12. FOR MORE DETAILS PLEASE VISIT OUR WEBSITE CONTACT US Orion Market Research Pvt. Ltd. (OMR Global)116, Shagun Arcade, Vijay Nagar Square, Indore, Madhya PradeshIndia- 452010 Global +1 646-755-7667 Asia +91 917-982-8694 info@omrglobal.com https://www.omrglobal.com

More Related